首页> 美国政府科技报告 >Cloning of Tumor Suppressor Genes in Breast Cancer
【24h】

Cloning of Tumor Suppressor Genes in Breast Cancer

机译:乳腺癌肿瘤抑制基因的克隆

获取原文

摘要

Breast cancer arises through the accumulation of genetic alterations that affect two classes of genes, ongogenes and tumor suppressor genes. These genes must be identified for several reasons. Characterization of the genes that drive carcinogenesis will facilitate a better understanding of cancer development. As part of this big picture, we have studied tumor suppressor genes involved in breast cancer. A tumor suppressor candidate, DBC2 was analyzed. DBC2 is composed of a RAS domain, protein-protein interacting domains, and DNA binding domain. DBC2 expression is extinguished by hypermethylation in more than half of breast tumors we tested. When DBC2 expression was induced in tumor Cells, the cell growth was expressed. Additionally, mutants we discovered in breast cancer specimens were found to lack the tumor suppressor function. We are studying DBC2's physiological roles by expression microarray analysis, protein- protein interaction studies, and functional analysis. We have identified several genes upregulated by DBC2 and potential candidates for interaction. We have also established techniques to control DBC2 expression, both induction and suppression, which will facilitate further analysis of DBC2.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号